What Is The Forecast Growth Rate For The Pediatric Neurology Device Market?
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.
Market Growth Dynamics
Recent Growth and Projections
- 2023 Market Size: $2.33 billion
- 2024 Projection: $2.5 billion
- CAGR: 7.1%
- Historic Growth Drivers:
- Increased awareness and early diagnosis
- Government support for pediatric healthcare
- Collaborations in pediatric neurological research
- Improvements in healthcare infrastructure
- Growing prevalence of pediatric neurological disorders
- Patient advocacy and support groups
Future Growth Outlook
- 2028 Projection: $3.17 billion
- CAGR: 6.1%
- Forecast Growth Drivers:
- Global emphasis on child health
- Integration of personalized medicine
- Rising awareness of early intervention
- Global health policies for children
- International collaboration in pediatric healthcare
Read More On The Pediatric Neurology Device Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pediatric-neurology-device-global-market-report
Key Trends Shaping the Market
Technological Advancements
- Wearable Neurological Monitoring Devices: Enhanced patient monitoring capabilities
- AI in Diagnostic Tools: Improved accuracy and efficiency
- Pediatric-Specific Neuromodulation Devices: Tailored treatments for young patients
- Expansion of Telehealth: Remote monitoring solutions
- Child-Friendly Neuroimaging Technologies: Comfortable diagnostic experiences
- Focus on Non-invasive Interventions: Minimally invasive treatment options
Driving Factors Behind Market Expansion
Rise in Autism Prevalence
- Impact on Market: Driving demand for diagnostic and therapeutic devices
- Statistics: 2.8% of 8-year-old children identified with ASD in the US
- Device Contributions: Enhancing quality of life, social skills, and behavioral symptoms management
Major Players in the Market
- Leading Companies:
- Johnson & Johnson Co
- Abbott Laboratories
- Medtronic PLC
- Fujifilm Holdings Corporation
- Siemens Healthineers AG
- Koninklijke Philips NV
- Others: Stryker, GE Healthcare, Baxter, Boston Scientific, etc.
Innovations Driving Revenue Growth
Neuromodulation Devices
- External Trigeminal Nerve Stimulation Devices: Minimally invasive treatment for ADHD
- Example: NeuroSigma’s Monarch eTNS System
- Features: Forehead patch delivering electrical pulses during sleep
- Clinical Benefits: Significant improvement in ADHD symptoms compared to placebo
Strategic Acquisitions
Strengthening Market Presence
- Acquisition Example: ArchiMed SAS acquires Natus Medical Incorporated
- Value: $1.1 billion investment
- Purpose: Enhance product line, expand internationally, leverage operational expertise
Market Segmentation
Detailed Analysis
- Product Types: Neurostimulation, Neurosurgery, Interventional Neurology, CSF Management, Others
- Conditions: Stroke, Seizures, Hydrocephalus, Oncology, Other Pediatric Conditions
- Services and Treatments: EEG, Baclofen Therapy, Neurological Evaluations, Vagal Nerve Stimulation, Others
- End Users: Hospitals, Ambulatory Surgery Centers, Other Healthcare Facilities
Regional Insights
- 2023 Leader: North America
- Growth Potential: Emerging opportunities in Asia-Pacific
The pediatric neurology device market is experiencing robust growth driven by technological advancements, rising awareness, and strategic investments. With innovations catering to specific pediatric needs and increasing prevalence of neurological disorders, the market is poised for significant expansion in the coming years.
Request for A Sample Of The Global Pediatric Neurology Device Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13506&type=smp